Since GLP-1 patches arent FDA approved, theres no guarantee of quality or consistency, and they havent been tested in clinical trials, so theres no long-term safety data
The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide both measured outcomes over 6872 weeks, and researchers have documented significant weight regain in patients who discontinue treatment prematurely
Diabetes pharmacotherapy has changed more in the last decade than in the four decades before it
Oxidative stress and signaling disruption increase neuronal vulnerability to inflammation and promote excess neurotoxic amyloid- peptides, which are key in the pathology of Alzheimers disease (AD) pathology (172)
"They make RLS worse in a very particular way - symptoms start earlier and earlier in the day and may go from the legs to the arms and sometimes upper torso as well," Dr
doi: 10.1111/resp.12312 41 AustinPC